U.S. Logistics Stock News

NasdaqGS:UPST
NasdaqGS:UPSTConsumer Finance

Upstart Holdings (UPST) Turns TTM Profitable Challenging Bearish Narratives On Its Rich 60.5x P/E

Upstart Holdings (UPST) has closed out FY 2025 with Q4 revenue of US$304.2 million and basic EPS of US$0.19, rounding off a trailing twelve month profile that includes US$1.1 billion in revenue and EPS of US$0.56 as the company moved into positive earnings territory over the year. The company has seen quarterly revenue move from US$220.4 million in Q1 2025 to US$304.2 million in Q4, while basic EPS tracked from a loss of US$0.03 in Q1 to profits of US$0.06, US$0.33 and then US$0.19 in Q2, Q3...
NYSE:SFL
NYSE:SFLOil and Gas

SFL Corp (SFL) Q3 Profit Return Tests Bullish Long Term Earnings Narrative

SFL (NYSE:SFL) has just posted its FY 2025 third quarter numbers, with revenue of US$175.2 million and EPS of US$0.07. This sets a fresh datapoint for a year that has swung from a loss per share of US$0.24 in Q1 to a small profit in Q2 and Q3. The company has seen quarterly revenue move from US$188.6 million in Q2 2024 to US$253.2 million in Q3 2024, and then settle in a range between US$175.2 million and US$188.5 million across the first three quarters of 2025. EPS has shifted from US$0.34...
NasdaqCM:SMX
NasdaqCM:SMXElectronic

SMX (Security Matters) (SMX) Is Up 62.3% After Expanding US$250 Million Equity Line of Credit - What's Changed

SMX (Security Matters) recently amended its equity line of credit, lifting the total capital commitment to US$250 million and extending its financing runway into 2028 to support brand protection, authentication, and track-and-trace initiatives. This enlarged and longer-term funding pool gives SMX more flexibility to run multiple platform deployments simultaneously and pursue longer-horizon enterprise and government projects without compressing implementation timelines. Given the strong 7-day...
NasdaqGS:FFIN
NasdaqGS:FFINBanks

First Financial Bankshares Leadership Shift And What It Means For Valuation

First Financial Bankshares (NasdaqGS:FFIN) has appointed David Bailey as Chief Executive Officer and President. Long-time leader F. Scott Dueser is transitioning to the role of Executive Chairman after many years in top executive positions. The leadership changes mark a new chapter for the company while keeping both executives in key roles. First Financial Bankshares, a regional banking group, sits in a sector that continues to see pressure around funding costs, loan growth, and regulation...
NasdaqGS:FISV
NasdaqGS:FISVDiversified Financial

Fiserv (FISV) Margin Expansion Story Tested By 1.4% Revenue Growth

Fiserv (FISV) has wrapped up FY 2025 with fourth quarter revenue of US$5.3b and basic EPS of US$1.51, alongside trailing twelve month revenue of US$21.2b and EPS of US$6.34 that frame the full year picture. Over recent periods the company has seen quarterly revenue range from US$5.1b to US$5.5b, while basic EPS has moved between US$0.98 and US$1.86. This gives you a clear view of how the top line and per share earnings have tracked into the latest print. With a trailing net margin of 16.4%...
NasdaqGS:DOX
NasdaqGS:DOXIT

Amdocs CEO Change And Dividend Lift While Shares Trade Below Targets

Amdocs announced that CEO Shuky Sheffer will retire, and long-time executive Shimie Hortig is set to become Chief Executive Officer. The company also approved an increase in its quarterly dividend, signaling an adjustment to its shareholder return policy. These updates arrive as Amdocs (NasdaqGS: DOX) trades at a share price of $73.13. Amdocs (NasdaqGS: DOX) is going through a leadership handover at the top at the same time its share price has been under pressure. The stock is at $73.13,...
NYSE:XPEV
NYSE:XPEVAuto

Discover Autodesk And 2 Other Stocks Estimated To Be Trading Below Fair Value

As the U.S. stock market kicks off February with significant gains, highlighted by the Dow Jones Industrial Average's 515-point surge and the S&P 500 nearing a record high, investors are keenly observing opportunities amid this bullish sentiment. In such an environment, identifying stocks that may be trading below their fair value can present potential investment opportunities, particularly when considering companies like Autodesk and others that might offer strong fundamentals at attractive...
NYSE:PAY
NYSE:PAYDiversified Financial

High Insider Ownership Fuels Growth Stocks In February 2026

As February 2026 begins, U.S. stock markets have shown strong momentum with major indexes like the Dow and S&P 500 ending sharply higher, reflecting investor optimism amid recent economic developments such as trade deals and manufacturing growth. In this buoyant market environment, companies with high insider ownership often attract attention as their leadership's vested interest can signal confidence in long-term growth potential.
NasdaqGS:UDMY
NasdaqGS:UDMYConsumer Services

Cassava Sciences And 2 Other Promising Penny Stocks

As February begins, major U.S. stock indexes have shown a strong start, with the Dow Jones Industrial Average adding 515 points and the S&P 500 nearing record highs. In this context of market optimism, investors may find interest in exploring penny stocks—an investment area that often involves smaller or newer companies. Although the term "penny stocks" might seem outdated, these investments can still offer surprising value and potential for growth when backed by solid financial health.
NasdaqCM:ISBA
NasdaqCM:ISBABanks

Undiscovered Gems in the US Market This February 2026

As February 2026 begins, the U.S. stock market is experiencing a strong start with major indices like the Dow Jones and S&P 500 showing significant gains, reflecting a positive investor sentiment despite recent economic uncertainties such as delayed jobs data due to a government shutdown. In this vibrant yet complex environment, identifying promising small-cap stocks requires careful consideration of factors like market resilience and growth potential amidst evolving economic conditions.
NYSE:EVMN
NYSE:EVMNBiotechs

Evommune (EVMN) Valuation Check After Positive Phase 2a EVO301 Results In Atopic Dermatitis

Evommune (EVMN) is back in focus after reporting statistically significant positive top-line results from its Phase 2a EVO301 trial in moderate to severe atopic dermatitis, including clear separation from placebo and a favorable safety readout. See our latest analysis for Evommune. The positive EVO301 data has coincided with a sharp re-rating in the stock, with a 1-day share price return of 70.87% and a year-to-date share price return of 67.71% off a last close of $29.03. This indicates...
NasdaqGM:ALVO
NasdaqGM:ALVOBiotechs

Assessing Alvotech (ALVO) Valuation After AVT80 Trial Success And New Sandoz Agreements

Alvotech (ALVO) shares have been in focus after the company reported positive top line pharmacokinetic data for its AVT80 biosimilar candidate to Entyvio, along with new supply and commercialization agreements with Sandoz in Canada, Australia and New Zealand. See our latest analysis for Alvotech. These fresh clinical results and the Sandoz agreements come after a mixed share price pattern, with a 12.07% 1 month share price return and a 4.00% year to date share price return contrasting with a...